259 related articles for article (PubMed ID: 11224996)
41. A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia.
Liu JF; Jamieson GG; Wu TC; Zhu GJ; Drew PA
Ann Surg Oncol; 2009 May; 16(5):1397-402. PubMed ID: 19241108
[TBL] [Abstract][Full Text] [Related]
42. Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.
Orringer MB; Forastiere AA; Perez-Tamayo C; Urba S; Takasugi BJ; Bromberg J
Ann Thorac Surg; 1990 Mar; 49(3):348-54; discussion 354-5. PubMed ID: 2106845
[TBL] [Abstract][Full Text] [Related]
43. Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective study.
Heroor A; Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Sudo T; Matono S; Yamana H; Shirouzu K
Dig Surg; 2003; 20(3):229-35; discussion 236-7. PubMed ID: 12759503
[TBL] [Abstract][Full Text] [Related]
44. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
[TBL] [Abstract][Full Text] [Related]
45. Treatment of oesophageal cancer with preoperative chemoradiotherapy may increase operative mortality.
Balart J; Balmaña J; Rius X; Salazar R; Gallen M; Navarro S; Arcusa A; Gallardo E; Brunet J
Eur J Surg Oncol; 2003 Dec; 29(10):884-9. PubMed ID: 14624782
[TBL] [Abstract][Full Text] [Related]
46. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus.
Stockeld D; Tennvall J; Wagenius G; Albertsson M; Backman L; Brodin O; Cwikiel M; Granström L; Gustafsson G; Gustavsson S; Hambraeus G; Lewensohn R; Sjöstedt S; Strander H; Aberg B; Fagerberg J
Acta Oncol; 2001; 40(5):566-73. PubMed ID: 11669327
[TBL] [Abstract][Full Text] [Related]
47. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
Orditura M; Galizia G; Napolitano V; Martinelli E; Pacelli R; Lieto E; Aurilio G; Vecchione L; Morgillo F; Catalano G; Ciardiello F; Del Genio A; Di Martino N; De Vita F
Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
[TBL] [Abstract][Full Text] [Related]
48. The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer.
Wojcieszynski AP; Berman AT; Wan F; Plastaras JP; Metz JM; Mitra N; Apisarnthanarax S
Cancer; 2013 Jun; 119(11):1976-84. PubMed ID: 23400669
[TBL] [Abstract][Full Text] [Related]
49. Surgical therapy for squamous-cell carcinoma of the oesophagus.
Chung SC; Stuart RC; Li AK
Lancet; 1994 Feb; 343(8896):521-4. PubMed ID: 7509430
[No Abstract] [Full Text] [Related]
50. Chemoradiation as primary management of esophageal cancer.
Coia LR
Semin Oncol; 1994 Aug; 21(4):483-92. PubMed ID: 8042046
[No Abstract] [Full Text] [Related]
51. Patterns of failure following combined modality therapy for esophageal cancer, 1984-1990.
Kavanagh B; Anscher M; Leopold K; Deutsch M; Gaydica E; Dodge R; Allen K; Allen D; Staub W; Montana G
Int J Radiat Oncol Biol Phys; 1992; 24(4):633-42. PubMed ID: 1429085
[TBL] [Abstract][Full Text] [Related]
52. [Esophageal carcinoma: current status of the therapy].
Lopez M
Clin Ter; 1984 Nov; 111(3):271-7. PubMed ID: 6083841
[No Abstract] [Full Text] [Related]
53. Toxicity, response rates and survival outcomes of induction cisplatin and irinotecan followed by concurrent cisplatin, irinotecan and radiotherapy for locally advanced esophageal cancer.
Watkins JM; Zauls AJ; Kearney PL; Shirai K; Ruppert BN; Harper JL; Sherman CA; Aguero EG; Reed CE; Sharma AK
Jpn J Clin Oncol; 2011 Mar; 41(3):334-42. PubMed ID: 21084436
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
55. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy.
Doty JR; Salazar JD; Forastiere AA; Heath EI; Kleinberg L; Heitmiller RF
Ann Thorac Surg; 2002 Jul; 74(1):227-31; discussion 231. PubMed ID: 12118764
[TBL] [Abstract][Full Text] [Related]
56. A case of advanced esophageal cancer with extensive lymph node metastases successfully treated with multimodal therapy.
Shigemitsu K; Naomoto Y; Shirakawa Y; Haisa M; Gunduz M; Tanaka N
Jpn J Clin Oncol; 2002 Aug; 32(8):310-4. PubMed ID: 12411570
[TBL] [Abstract][Full Text] [Related]
57. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
58. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
Girvin GW; Matsumoto GH; Bates DM; Garcia JM; Clyde JC; Lin PH
Am J Surg; 1995 May; 169(5):557-9. PubMed ID: 7747839
[TBL] [Abstract][Full Text] [Related]
59. [Neoadjuvant therapy of adenocarcinomas of the upper gastrointestinal tract. Status of radiotherapy].
Semrau R; Vallböhmer D; Hölscher AH; Müller RP
Chirurg; 2009 Nov; 80(11):1035-41. PubMed ID: 19820906
[TBL] [Abstract][Full Text] [Related]
60. [The surgical and combined treatments of locally disseminated cardioesophageal cancer].
Davydov MI; Mazurin VS; Kuz'michev VA; Kiladze MA
Khirurgiia (Mosk); 1992 Mar; (3):44-7. PubMed ID: 1434364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
